L-Glutamic acid α-tert·butyl ester

Details:

Chengdu Baishixing Science and Technology Industry Co., Ltd. was founded in 2003, specializing in the research and development, production of amino acid series products and pharmaceutical intermediates. The company mainly operates four series of products (protected amino acids, cell culture raw materials, Bioactive substances and custom-made intermediates ), with an annual output of over 1000 tons. There are 2 exclusive domestic production varieties and multiple invention patents, and the products comply with the standards of the US Pharmacopoeia (USP), Japan's AJI, and the European Pharmacopoeia (EP). The company has passed the Chinese supplier certification of ISO9001 (2015), ISO14001 (2015), ISO22000 (2005), OHSAS18001 (2007) and other systems, and is a second level standardized safety production enterprise, deeply trusted by domestic and foreign users.

Gansu Province Baishixing Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Chengdu Baishixing Science and Technology Industry Co., Ltd. It focuses on the development and production of small molecule pharmaceutical raw materials, high-end pharmaceutical intermediates, and new compounds. It is a high-tech enterprise that provides large-scale products and technical services related to raw materials and pharmaceutical intermediates to global pharmaceutical enterprises and research institutions. The company is located in the national level new area, Lanzhou New Area Chemical Industry Park, covering an area of over 90 acres.

Baishixing has always been based in domestic and international markets, committed to becoming the preferred raw material supplier for the world's pharmaceutical and high-end food industries. To become a first-class production enterprise for cell culture media and make contributions to human health.